부산대학교 도서관

Rohaan, M.W. ; Gomez-Eerland, R. ; van den Berg, J.H. ; Geukes Foppen, M.H. ; van Zon, M. ; Raud, B. ; Jedema, I. ; Scheij, S. ; de Boer, R. ; Bakker, N.A.M. ; van den Broek, D. ; Pronk, L.M. ; Grijpink-Ongering, L.G. ; Sari, A. ; Kessels, R. ; van den Haak, M. ; Mallo, H.A. ; Karger, M. ; van de Wiel, B.A. ; Zuur, C.L. ; Duinkerken, C.W. ; Lalezari, F. ; van Thienen, J.V. ; Wilgenhof, S. ; Blank, C.U. ; Beijnen, J.H. ; Nuijen, B. ; Schumacher, T.N. ; Haanen, J.B.A.G.

In Immuno-Oncology and Technology September 2022 15

Kuilman T; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands. thomas.kuilman@astrazeneca.com.; Schrikkema DS; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Gadiot J; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Gomez-Eerland R; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Bies L; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Walker J; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Spaapen RM; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Kok H; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Houg D; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Viyacheva M; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Claassen YB; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Saornil M; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Krijgsman O; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Stringer B; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Ding H; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Geleijnse A; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Meinema AC; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Weissbrich B; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Lancee M; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Engele CG; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Sabatino M; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Chen PL; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Tsai KY; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Mulé JJ; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Immunology and Radiation Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.; Sondak VK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; van den Bulk J; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; de Miranda NF; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Jedema I; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Haanen JG; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van Heijst JWJ; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Schumacher TN; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Linnemann C; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands.; Bendle GM; Neogene Therapeutics, A member of the AstraZeneca Group, Amsterdam, The Netherlands. gavin.bendle@astrazeneca.com.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Beiping Miao; Zhaoqing Hu; Riccardo Mezzadra; Lotte Hoeijmakers; Astrid Fauster; Shangce Du; Zhi Yang; Melanie Sator-Schmitt; Helena Engel; Xueshen Li; Caroline Broderick; Guangzhi Jin; Raquel Gomez-Eerland; Lisette Rozeman; Xin Lei; Hitoshi Matsuo; Chen Yang; Ingrid Hofland; Dennis Peters; Annegien Broeks; Elke Laport; Annika Fitz; Xiyue Zhao; Mohamed A.A. Mahmoud; Xiujian Ma; Sandrine Sander; Hai-kun Liu; Guoliang Cui; Yu Gan; Wei Wu; Yanling Xiao; Albert J.R. Heck; Wenxian Guan; Scott W. Lowe; Hugo M. Horlings; Cun Wang; Thijn R. Brummelkamp; Christian U. Blank; Ton N.M. Schumacher; Chong Sun

Cancer Cell

Meike E. W. Logtenberg; J. H. Marco Jansen; Matthijs Raaben; Mireille Toebes; Katka Franke; Arianne M. Brandsma; Hanke L. Matlung; Astrid Fauster; Raquel Gomez-Eerland; Noor A. M. Bakker; Simone van der Schot; Koen A. Marijt; Martijn Verdoes; John B. A. G. Haanen; Joost H. van den Berg; Jacques Neefjes; Timo K. van den Berg; Thijn R. Brummelkamp; Jeanette H. W. Leusen; Ferenc A. Scheeren; Ton N. Schumacher

Nat Med
Nature Medicine, 25, 4, pp. 612-619
Nature Medicine

Mezzadra, R.; Sun, C.; Jae, L.T.; Gomez-Eerland, R.; Vries, E. de; Wu, W.; Logtenberg, M.E.W.; Slagter, M.; Rozeman, E.A.; Hofland, I.; Broeks, A.; Horlings, H.M.; Wessels, L.F.A.; Blank, C.U.; Xiao, Y.L.; Heck, A.J.R.; Borst, J.; Brummelkamp, T.R.; Schumacher, T.N.M.

Nature

Gee, Marvin H. ; Han, Arnold ; Lofgren, Shane M. ; Beausang, John F. ; Mendoza, Juan L. ; Birnbaum, Michael E. ; Bethune, Michael T. ; Fischer, Suzanne ; Yang, Xinbo ; Gomez-Eerland, Raquel ; Bingham, David B. ; Sibener, Leah V. ; Fernandes, Ricardo A. ; Velasco, Andrew ; Baltimore, David ; Schumacher, Ton N. ; Khatri, Purvesh ; Quake, Stephen R. ; Davis, Mark M. ; Garcia, K. Christopher

In Cell 25 January 2018 172(3):549-563

Linnemann, C.; Heemskerk, B.; Kvistborg, P.; Kluin, R.J.C.; Bolotin, D.A.; Chen, X.J.; Bresser, K.; Nieuwland, M.; Schotte, R.; Michels, S.; Gomez-Eerland, R.; Jahn, L.; Hombrink, P.; Legrand, N.; Shu, C.J.; Mamedov, I.Z.; Velds, A.; Blank, C.U.; Haanen, J.B.A.G.; Turchaninova, M.A.; Kerkhoven, R.M.; Spits, H.; Hadrup, S.R.; Heemskerk, M.H.M.; Blankenstein, T.; Chudakov, D.M.; Bendle, G.M.; Schumacher, T.N.M.

Nature Medicine. 19:1534-1541

Riccardo Mezzadra; Marjolein de Bruijn; Lucas T Jae; Raquel Gomez-Eerland; Anja Duursma; Ferenc A Scheeren; Thijn R Brummelkamp; Ton N Schumacher

PLoS ONE, Vol 14, Iss 2, p e0212053 (2019)

Logtenberg, M.E.W.; Jansen, J.H.M.; Raaben, M.; Toebes, M.; Franke, K.; Brandsma, A.M.; Matlung, H.L.; Fauster, A.; Gomez-Eerland, R.; Bakker, N.A.M.; Schot, S. van der; Marijt, K.A.; Verdoes, M.; Haanen, J.B.A.G.; Berg, J.H. van den; Neefjes, J.; Berg, T.K. van den; Brummelkamp, T.R.; Leusen, J.H.W.; Scheeren, F.A.; Schumacher, T.N.

van der Heijden, I. ; Gomez-Eerland, R. ; van den Berg, J.H. ; Oosterhuis, K. ; Schumacher, T.N. ; Haanen, J.B.A.G. ; Beijnen, J.H. ; Nuijen, B.

In Vaccine 11 July 2013 31(32):3274-3280

S. Ariotti; J.B. Beltman; G. Chodaczek; M.E. Hoekstra; A.E. van Beek; R. Gomez-Eerland; L. Ritsma; J. van Rheenen; A.F. Marxe9e; T. Zal; R.J. de Boer; J.B. Haanen; T.N. Schumacher.

Proceedings of the National Academy of Sciences. 109:19739-19744

Mezzadra, Riccardo; Bruijn, Marjolein de; Jae, Lucas T.; Gomez-Eerland, Raquel; Duursma, Anja; Scheeren, Ferenc A.; Brummelkamp, Thijn R.; Schumacher, Ton N.

M.W. Rohaan; R. Gomez-Eerland; M H Geukes Foppen; M. van Zon; R. de Boer; N.A.M. Bakker; L.M. Pronk; A. Sari; H.A. Mallo; B.A. van de Wiel; F. Lalezari; J.H. Beijnen; B. Nuijen; H. van Tinteren; J.V. van Thienen; C.U. Blank; S. Wilgenhof; T.N. Schumacher; J.H. van den Berg; J B A G Haanen

Annals of Oncology. 30:v481-v482

Berg, J.H. van den; Heemskerk, B.; Rooij, N. van; Gomez-Eerland, R.; Michels, S.; Zon, M. van; Boer, R. de; Bakker, N.A.M.; Jorritsma-Smit, A.; Buuren, M.M. van; Kvistborg, P.; Spits, H.; Schotte, R.; Mallo, H.; Karger, M.; Hage, J.A. van der; Wouters, M.W.J.M.; Pronk, L.M.; Foppen, M.H.G.; Blank, C.U.; Beijnen, J.H.; Nuijen, B.; Schumacher, T.N.; Haanen, J.B.A.G.

J Immunother Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

Linnemann, C.; Heemskerk, B.; Kvistborg, P.; Kluin, R.J.C.; Bolotin, D.A.; Chen, X.; Bresser, K.; Nieuwland, M.; Schotte, R.; Michels, S.; Gomez-Eerland, R.; Jahn, L.; Shu, C.J.; Kerkhoven, R.M.; Spits, H.; Hadrup, S.R.; Heemskerk, M.H.M.; Blankenstein, T.; Chudakov, D.M.; Bendle, G.M.; Schumacher, T.N.M.

Chong Sun; Riccardo Mezzadra; Lucas T. Jae; Raquel Gomez-Eerland; Evert de Vries; Wei Wu; Yanling Xiao; Albert J. Heck; Jannie Borst; Thijn R. Brummelkamp; Ton N. Schumacher

Cancer Research. 77:LB-291

Vredevoogd DW; Kuilman T; Ligtenberg MA; Boshuizen J; Stecker KE; de Bruijn B; Krijgsman O; Huang X; Kenski JCN; Lacroix R; Mezzadra R; Gomez-Eerland R; Yildiz M; Dagidir I; Apriamashvili G; Zandhuis N; van der Noort V; Visser NL; Blank CU; Altelaar M; Schumacher TN; Peeper DS

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE; PubMed not MEDLINE

Vredevoogd DW; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Kuilman T; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Ligtenberg MA; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Boshuizen J; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Stecker KE; Biomolecular Mass Spectrometry and Proteomics, Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, the Netherlands.; de Bruijn B; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Krijgsman O; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Huang X; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Kenski JCN; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Lacroix R; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Mezzadra R; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Gomez-Eerland R; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Yildiz M; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Dagidir I; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Apriamashvili G; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Zandhuis N; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; van der Noort V; Division of Statistics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Visser NL; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Blank CU; Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Altelaar M; Proteomics Facility, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, the Netherlands.; Schumacher TN; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.; Peeper DS; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: d.peeper@nki.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

van den Berg JH; Division of Immunology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Amsterdam Biotherapeutics Unit, Amsterdam, The Netherlands.; Gomez-Eerland R; Division of Immunology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; van de Wiel B; Division of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Hulshoff L; Division of Anesthesiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; van den Broek D; Division of Clinical Chemistry, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Bins A; Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Tan HL; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Harper JV; Immunocore Limited, Oxfordshire, UK.; Hassan NJ; Immunocore Limited, Oxfordshire, UK.; Jakobsen BK; Immunocore Limited, Oxfordshire, UK.; Jorritsma A; Division of Immunology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Blank CU; Division of Immunology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Schumacher TN; Division of Immunology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Haanen JB; Division of Immunology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Mezzadra, Riccardo; de Bruijn, Marjolein; Jae, Lucas T.; Gomez-Eerland, Raquel; Duursma, Anja; Scheeren, Ferenc A.; Brummelkamp, Thijn R.; Schumacher, Ton N.

PLoS ONE; 2/12/2019, Vol. 14 Issue 2, p1-16, 16p